Solid Biosciences Inc. (SLDB)
NASDAQ · Healthcare
Solid Biosciences Inc. Total Liabilities 2016–2022
Solid Biosciences Inc. annual total liabilities history from 2017 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Solid Biosciences Inc. total liabilities as of December 31, 2022: 48.6M, a 101.03% increase year-over-year.
- Solid Biosciences Inc. total liabilities for 2022 were 48.6M, a 101.03% increase from 2021.
- Solid Biosciences Inc. total liabilities for 2021 were 24.2M, a 38.16% decrease from 2020.
- Solid Biosciences Inc. total liabilities for 2020 were 39.1M, a 66.86% increase from 2019.
- Solid Biosciences Inc. total liabilities for 2019 were 23.4M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Solid Biosciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $49 |
| 2021 | $24 |
| 2020 | $39 |
| 2019 | $23 |
| 2018 | $14 |
| 2017 | $11 |
Solid Biosciences Inc. Total Liabilities — FAQ
Solid Biosciences Inc. (SLDB) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SLDB's total liabilities history?
The chart and table above show Solid Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.